Approaches to multimodality imaging of angiogenesis

Journal of Nuclear Medicine

Volumn 51, Issue SUPPL.1, 2010, Pages

  Dobrucki, Lawrence W ^a   De Muinck, Ebo D ^b   Lindner, Jonathan R ^c   Sinusas, Albert J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LINKÖPING UNIVERSITY   (Sweden)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CELL GROWTH; ECHOGRAPHY; HUMAN; MICROVASCULATURE; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; CHEMISTRY; DIAGNOSTIC IMAGING; GENETICS; METHODOLOGY; MOUSE; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RISK; TREATMENT OUTCOME; ULTRASOUND;

CONTRAST MEDIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPITOPE; TECHNETIUM;

ANIMALS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; EPITOPES; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; RISK; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; ULTRASONICS;

EID: 77953065250     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.074963     Document Type: Review

References (68)

1. Fam NP, Verma S, Kutryk M, Stewart DJ. Clinician guide to angiogenesis. Circulation. 2003;108:2613-2618.
2. Sinusas A. Imaging of angiogenesis. J Nucl Cardiol. 2004;11:617-633.
3. Simons M, Bonow R, Chronos N, et al. Clinical trials in coronary angiogenesis: issues, problems, consensus - an expert panel summary. Circulation. 2000;102:E73-E86.
4. Lake Tahoe invitation meeting 2002. J Nucl Cardiol. 2003;10:223-257.
5. 124I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography. Cancer Res. 2002;62:5912-5919.
6. 123I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy. Int J Cancer. 2001;91:789-796.
7. Cai W, Chen K, Mohamedali K, et al. PET of vascular endothelial growth factor receptor expression. J Nucl Med. 2006;47:2048-2056.
8. Rodriguez-Porcel M, Cai W, Gheysens O, et al. Imaging of VEGF receptor in a rat myocardial infarction model using PET. J Nucl Med. 2008;49:667-673.
9. Backer M, Levashova Z, Patel V, et al. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nat Med. 2007;13:504-509.
10. Levashova Z, Backer M, Backer J, Blankenberg F. Imaging vascular endothelial growth factor (VEGF) receptors in turpentine-induced sterile thigh abscesses with radiolabeled single-chain VEGF. J Nucl Med. 2009;50:2058-2063.
11. Wagner B, Anton M, Nekolla S, et al. Noninvasive characterization of myocardial molecular interventions by integrated positron emission tomography and computed tomography. J Am Coll Cardiol. 2006;48:2107-2115.
12. Sipkins D, Cheresh D, Kazemi M, Nevin L, Bednarski M, Li K. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med. 1998;4:623-626.
13. Haubner R. Noninvasive tracer techniques to characterize angiogenesis. Handb Exp Pharmacol. 2008(185 Pt 2):323-339.
14. Harris T, Kalogeropoulos S, Nguyen T, et al. Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy. Cancer Biother Radiopharm. 2003;18:627-641.
15. Sadeghi MM. Imaging avb3 integrin in vascular injury: does this reflect increased integrin expression or activation? [abstract]. Circulation. 2003;108(17 suppl):1868.
16. Meoli DF, Sadeghi MM, Krassilnikova S, et al. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest. 2004;113:1684-1691.
17. Kalinowski L, Dobrucki L, Meoli D, et al. Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction. J Appl Physiol. 2008;104:1504-1512.
18. Liu S, Liu Z, Chen K, et al. 18F-labeled galacto and PEGylated RGD dimers for PET imaging of alpha(v)beta(3) integrin expression. Mol Imaging Biol. 2009 [Epub ahead of print].
19. Liu S. Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)- targeted radiotracers: maximizing binding affinity via bivalency. Bioconjug Chem. 2009;20:2199-2213.
20. Dijkgraaf I, Beer A, Wester H. Application of RGD-containing peptides as imaging probes for alphavbeta3 expression. Front Biosci. 2009;14:887-899.
21. 99mTc-labeled peptide targeted at alphavbeta3 integrin after murine hindlimb ischemia. Circulation. 2005;111:3255-3260.
22. Dobrucki L, Dione D, Kalinowski L, et al. Serial noninvasive targeted imaging of peripheral angiogenesis: validation and application of a semiautomated quantitative approach. J Nucl Med. 2009;50:1356-1363.
23. Lindsey M, Escobar G, Dobrucki L, et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Heart Circ Physiol. 2006;290:H232-H239.
24. Dobrucki LW, Tsutsumi Y, Kalinowski L, et al. Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging. J Mol Cell Cardiol. October 20, 2009 [Epub ahead of print].
25. Li S, Dobrucki LW, Sinusas AJ, Liu YH. A new method for SPECT quantification of targeted radiotracers uptake in the myocardium. Med Image Comput Comput Assist Interv. 2005;8:684-691.
26. Li S, Dobrucki WL, Aikawa R, Mendizabal M, Sinusas AJ, Liu Y. A new method for quantification of targeted radiotracer uptake from cardiac microSPECT/CT images: a rat validation. J Nucl Med. 47(suppl 1):253P.
27. Jaffer F, Libby P, Weissleder R. Molecular imaging of cardiovascular disease. Circulation. 2007;116:1052-1061.
28. Makowski M, Ebersberger U, Nekolla S, Schwaiger M. In vivo molecular imaging of angiogenesis, targeting alphavbeta3 integrin expression, in a patient after acute myocardial infarction. Eur Heart J. 2008;29:2201.
29. Welch M, Hawker C, Wooley K. The advantages of nanoparticles for PET. J Nucl Med. 2009;50:1743-1746.
30. Almutairi A, Rossin R, Shokeen M, et al. Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc Natl Acad Sci USA. 2009;106:685-690.
31. Kaufmann B, Lindner J. Molecular imaging with targeted contrast ultrasound. Curr Opin Biotechnol. 2007;18:11-16.
32. Lindner J. Contrast ultrasound molecular imaging of inflammation in cardiovascular disease. Cardiovasc Res. 2009;84:182-189.
33. Piedra M, Allroggen A, Lindner J. Molecular imaging with targeted contrast ultrasound. Cerebrovasc Dis. 2009;27(suppl 2):66-74.
34. Sinusas A, Bengel F, Nahrendorf M, et al. Multimodality cardiovascular molecular imaging, part I. Circ Cardiovasc Imaging. 2008;1:244-256.
35. Saraste A, Nekolla S, Schwaiger M. Cardiovascular molecular imaging: an overview. Cardiovasc Res. 2009;83:643-652.
36. Ellegala D, Leong-Poi H, Carpenter J, et al. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation. 2003;108:336-341.
37. Leong-Poi H, Christiansen J, Klibanov A, Kaul S, Lindner J. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation. 2003;107:455-460.
38. Leong-Poi H, Christiansen J, Heppner P, et al. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation. 2005;111:3248-3254.
39. Weller G, Wong M, Modzelewski R, et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res. 2005;65:533-539.
40. Willmann J, Paulmurugan R, Chen K, et al. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology. 2008;246:508-518.
41. Nahrendorf M, Sosnovik D, French B, et al. Multimodality cardiovascular molecular imaging, part II. Circ Cardiovasc Imaging. 2009;2:56-70.
42. Behm C, Kaufmann B, Carr C, et al. Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis. Circulation. 2008;117:2902-2911.
43. Jaffer F, Weissleder R. Seeing within: molecular imaging of the cardiovascular system. Circ Res. 2004;94:433-445.
44. Tran T, Caruthers S, Hughes M, et al. Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Int J Nanomedicine. 2007;2:515-526.
45. Joseph P, Yuasa Y, Kundel H, Mukherji B, Sloviter H. Magnetic resonance imaging of fluorine in rats infused with artificial blood. Invest Radiol. 1985;20:504-509.
46. Cosgrove D. Ultrasound contrast agents: an overview. Eur J Radiol. 2006;60:324-330.
47. Winter PM, Caruthers SD, Kassner A, et al. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res. 2003;63:5838-5843.
48. Kluza E, van der Schaft DW, Hautvast PA, et al. Synergistic targeting of alpha(v)beta(3) integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis. Nano Lett. 2010;10:52-58.
49. Thorek D, Chen A, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng. 2006;34:23-38.
50. Zhang C, Jugold M, Woenne E, et al. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res. 2007;67:1555-1562.
51. Montet X, Montet-Abou K, Reynolds F, Weissleder R, Josephson L. Nanoparticle imaging of integrins on tumor cells. Neoplasia. 2006;8:214-222.
52. Bruns O, Ittrich H, Peldschus K, et al. Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals. Nat Nanotechnol. 2009;4:193-201.
53. 19F nanoparticles. Magn Reson Med. 2004;52:1255-1262.
54. 19F NMR of VCAM-1 targeted nanobeacons. Nanomedicine. 2009;5:359-367.
55. Winter P, Morawski A, Caruthers S, et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation. 2003;108:2270-2274.
56. Wickline S, Neubauer A, Winter P, Caruthers S, Lanza G. Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology. Arterioscler Thromb Vasc Biol. 2006;26:435-441.
57. Oostendorp M, Douma K, Hackeng T, et al. Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots. Cancer Res. 2008;68:7676-7683.
58. Wang Y, de Rochefort L, Liu T, Kressler B. Magnetic source MRI: a new quantitative imaging of magnetic biomarkers. Conf Proc IEEE Eng Med Biol Soc. 2009;1:53-56.
59. Schabel M, Parker D. Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences. Phys Med Biol. 2008;53:2345-2373.
60. Liu W, Dahnke H, Rahmer J, Jordan E, Frank J. Ultrashort T2* relaxometry for quantitation of highly concentrated superparamagnetic iron oxide (SPIO) nanoparticle labeled cells. Magn Reson Med. 2009;61:761-766.
61. Bowen C, Zhang X, Saab G, Gareau P, Rutt B. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med. 2002;48:52-61.
62. de Lussanet Q, Langereis S, Beets-Tan R, et al. Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice. Radiology. 2005;235:65-72.
63. Lu E, Wagner W, Schellenberger U, et al. Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue. Circulation. 2003;108:97-103.
64. 18F-AH111585 in breast cancer patients. J Nucl Med. 2008;49:879-886.
65. 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy. J Nucl Med. 2009;50:116-122.
66. Johnson L, Schofield L, Donahay T, Bouchard M, Poppas A, Haubner R. Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium. JACC Cardiovasc Imaging. 2008;1:500-510.
67. v integrin expression is enhanced in ischemic murine hindlimbs. J Nucl Med. 2005;46:472-478.
68. Indrevoll B, Kindberg G, Solbakken M, et al. NC-100717: a versatile RGD peptide scaffold for angiogenesis imaging. Bioorg Med Chem Lett. 2006;16:6190-6193.